Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole and Misoprostol for Anembryonic Pregnancy
NCT05198050Completed
- Sponsor
- Cairo University
- Start
- Apr 2022
- Primary completion
- Sep 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of letrozole in Anembryonic pregnancy, sponsored by Cairo University. Primary endpoint: Complete abortion at 2 days. Started Apr 2022; status: completed.
02
Drugs
letrozole
03
Conditions
Anembryonic pregnancy
Beyond the preview
Go deeper on NCT05198050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05198050.